Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Total Non-Current Liabilities (2022 - 2025)

Updated

Odyssey Therapeutics (ODTX) recorded Total Non-Current Liabilities of $758.07 million in Q4 2025, up 30.7% from $579.96 million a year earlier.

Analysis

Odyssey Therapeutics (ODTX) Total Non-Current Liabilities (2022 - 2025) Analysis & Trends

  • Annual Total Non-Current Liabilities has a three-year compound annual growth rate of 122.8% (FY2022 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $579.96 million in FY2024 and $68.51 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 102.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 117.60 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -36.84 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 36.05 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 96.04 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 758.07 Mn
Dec 31, 2024 579.96 Mn
Dec 31, 2022 68.51 Mn
API Access

Odyssey Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ODTX&period=max&api_key=YOUR_API_KEY